Oncology Today with Dr Neil Love - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Oncology Today with Dr Neil Love — Health & Fitness
Oncology Today with Dr Neil Love

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Latest Episodes:

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis Jul 01, 2024

Show notes

Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer Jun 17, 2024

Show notes

Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer Jun 12, 2024

Show notes

Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and practical considerations with ovarian function suppression for hormone receptor-positive breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer Jun 11, 2024

Show notes

Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer Jun 07, 2024

Show notes

Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Key Presentations on Lymphoma from Recent Major Conferences May 28, 2024

Show notes

Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Bispecific Antibodies in the Management of Multiple Myeloma May 24, 2024

Show notes

Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.

CME information and select publications here.

Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia May 24, 2024

Show notes

Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer May 20, 2024

Show notes

Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.

CME information and select publications here.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia May 13, 2024

Show notes

Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Related Podcasts